Skip to main content

Table 1 Baseline characteristics of the intention to treat population

From: Point-of-care ultrasound of the heart and lungs in patients with respiratory failure: a pragmatic randomized controlled multicenter trial

 

Intervention group (n = 106)

Control group (n = 105)

Age (years; median (IQR)

68 (51–79)

69 (62–79)

Sex

 Male

62 (58%)

46 (44%)

 Female

44 (42%)

59 (56%)

Smoking status

 Never smoked

30 (28%)

25 (24%)

 Current smoker

27 (25%)

12 (11%)

 Previous smoker

24 (23%)

37 (35%)

 Unknown status

25 (24%)

31 (30%)

Medical history

 Apoplexy

9 (8%)

7 (7%)

 Coronary artery disease

17 (16%)

16 (15%)

 Heart failure

13 (12%)

14 (13%)

 Arterial hypertension

24 (23%)

22 (21%)

 Thromboembolic disease

11 (10%)

5 (5%)

 Chronic obstructive pulmonary disease

33 (31%)

32 (30%)

 Asthma

6 (6%)

6 (6%)

 Other pulmonary or pleural lung disease

11 (10%)

9 (9%)

 Diabetes mellitus

8 (8%)

17 (16%)

 Chronic kidney disease

8 (8%)

8 (8%)

 Other medical disease

28 (26%)

36 (34%)

 Psychiatric disorder

7 (7%)

4 (4%)

Medication at admission

 Β-blockers

28 (26%)

23 (22%)

 Diuretics

38 (36%)

49 (47%)

 Nitrates

9 (8%)

14 (13%)

 Angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker

26 (25%)

38 (36%)

 Digoxin

4 (4%)

5 (5%)

 Calcium-channel blockers

16 (15%)

21 (20%)

 Aspirin

16 (15%)

18 (17%)

 Inhaled bronchodilators

39 (37%)

45 (43%)

 Inhaled corticosteroids

21 (20%)

31 (30%)

 Oral corticosteroids

10 (9%)

17 (16%)

 Antibiotics

18 (17%)

17 (16%)

 Anticoagulants

29 (27%)

36 (34%)

 Immunosuppressive medication

5 (5%)

2 (2%)

 Other medication

19 (18%)

24 (23%)

Vital signs at admission mean, (min-max)

 Respiratory rate (breaths per min)

21 (12–44)

22 (12–40)

 Saturation (%)

94 (55–100)

95 (74–100)

-  of these patients n received oxygen supply (l/min)

23 (22%)

29 (28%)

o  1–3 l/min n (%)

15 (65%)

24 (83%)

o  4–6 l/min n (%)

8 (35%)

4 (14%)

o   > 6 l/min n (%)

0

1 (3%)

 Systolic blood pressure (mmHg)

137 (80–224)

137 (94–212)

 Diastolic blood pressure (mmHg)

78 (32–123)

78 (47–111)

 Heart rate (beats per minute)

90 (52–150)

86 (40–144)

 Temperature (°C)

37.1 (35.2–39.5)

37.2 (35.0–39.8)

 Blood glucose

6.8 (4.1–19.9)

6.6 (1.0–22.4)

 Glasgow coma scale scorea

15 (9–15)

15 (14–15)

Patients´ signs and symptoms upon admission

 Cough

33 (31%)

43 (41%)

 Dyspnoea

90 (85%)

85 (81%)

 Chest pain

28 (26%)

28 (27%)

 Respiration rate > 20 breaths per min

33 (30%)

30 (29%)

 Peripheral saturation < 95%

30 (28%)

24 (23%)

 None of the above

0

0

Ultrasound examination already performed in ambulance

0

0

 Patients severity score upon admissionb

-  I (Red)

5 (5%)

1 (1%)

-  II (Orange)

29 (27%)

36 (34%)

-  

49 (46%)

42 (40%)

-  III (Yellow)

-  IV (Green)

23 (22%)

27 (26%)

  1. Data are number (n), (%), mean (SD) or a median (IQR), unless otherwise indicated
  2. Data are not available for all randomized patients. Missing data are handled by multiple imputation for continuous data and simple imputation when binominary
  3. aWe found GCS 9 in one patient admitted with exacerbation in terminal COPD. Pt was immediately treated with NIV with effect, replied relevant on questions and signed informed consent. The remaining of the included patients had GCS from 14 to 15
  4. bThe severity score is made according to the Danish Emergency Process Triage (DEPT) criteria used for patients with acute illness. The severity score is assessed by measuring the patients´ vital parameters (e.g. BP, HR, GCS). `I (Red)´ is the most severe condition